Examkin

Soru

Zorluk: ZorEndocrinology and Metabolism

A 4444-year-old woman is evaluated for a 66-month history of progressive weight gain, new-onset facial hair growth, and easy bruising. Her blood pressure is 160/100160/100 mmHg. Physical examination reveals a rounded face, dorsocervical fat pad, prominent proximal muscle weakness, and wide, violaceous abdominal striae.

Arrange the following diagnostic steps in the most appropriate sequential order to establish the diagnosis and definitively localize the source of this patient's condition, assuming each successive biochemical test points toward a pituitary origin but initial anatomic imaging remains equivocal.

  1. 1Perform a 11-mg overnight dexamethasone suppression test
  2. 2Measure plasma adrenocorticotropic hormone (ACTH) concentration
  3. 3Perform a high-dose (88-mg) dexamethasone suppression test
  4. 4Obtain a magnetic resonance imaging (MRI) scan of the pituitary gland
  5. 5Perform bilateral inferior petrosal sinus sampling (IPSS)

Cevap

The correct sequence strictly follows the diagnostic algorithm for Cushing syndrome: confirm hypercortisolism, determine ACTH dependence, biochemically localize the ACTH source, attempt anatomic localization via imaging, and finally perform invasive sampling if imaging is equivocal.
The workup of Cushing syndrome must be highly stepwise to avoid false localizations. First, confirm excess cortisol (11-mg dexamethasone suppression test). Second, differentiate ACTH-independent from ACTH-dependent causes (plasma ACTH). Third, if ACTH-dependent, biochemically differentiate pituitary from ectopic sources (high-dose dexamethasone test). Fourth, attempt anatomic localization (pituitary MRI). Finally, if MRI does not show a clear adenoma larger than 66 mm, perform inferior petrosal sinus sampling to definitively confirm a central pituitary source prior to neurosurgery.

Adım Adım Çözüm

1
Establish the presence of hypercortisolism
Pathological hypercortisolism is confirmed via a 11-mg dexamethasone suppression test.
Prevents unnecessary, expensive, or invasive workups in patients with physiological variants, simple obesity, or pseudo-Cushing states.
2
Determine ACTH dependence
ACTH measurement distinguishes between primary adrenal pathology and central/ectopic drivers.
If ACTH is suppressed, the source is in the adrenal glands and an abdominal CT is needed. If ACTH is high/normal, the source is ACTH-dependent.
3
Differentiate the source of ACTH production
A high-dose dexamethasone test biochemically localizes the lesion to the pituitary gland.
Pituitary adenomas usually retain some negative feedback mechanisms and will suppress cortisol production at high dexamethasone doses, unlike most ectopic tumors.
4
Localize the suspected pituitary adenoma anatomically
An MRI of the pituitary gland is performed.
Imaging is required to identify a surgical target once biochemical testing confirms a pituitary origin.
5
Confirm pituitary source invasively
Bilateral inferior petrosal sinus sampling (IPSS) is performed.
Pituitary microadenomas can be too small to detect on MRI. Because incidental pituitary lesions occur in up to 10%10\% of the general population, IPSS is strictly required when MRI is equivocal to prevent operating on an incidentaloma while an ectopic ACTH source is missed.

Anahtar Kavram

The diagnostic algorithm for Cushing syndrome progresses sequentially: confirm hypercortisolism, establish ACTH dependence, differentiate the ACTH source biochemically, localize anatomically, and confirm with invasive sampling if imaging is indeterminate.

Alternatif Yöntem

Instead of the high-dose (88-mg) dexamethasone suppression test, a corticotropin-releasing hormone (CRH) stimulation test can also be used in step 3 to differentiate pituitary from ectopic ACTH sources. Pituitary adenomas typically respond to CRH with a robust increase in ACTH and cortisol, whereas ectopic sources generally do not.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Endocrinology and Metabolism

Bu konudan daha fazla soru